Develops and manufactures agricultural and noncrop products

Novomics develops cancer treatment-linked diagnosis systems based on its expertise and knowledge in the field of molecular diagnosis. A significant strength of Novomics is its network of specialists and clinicians, as well as the knowledge gains made possible by technological advancements in the age of precision medicine. By embracing cutting-edge clinical, molecular biological, and academic achievements and forming close collaborative relationships with pharmaceutical companies and hospitals that are significant players in the medical industry.

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia).

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. The Prostatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.

Evonik Operations GmbH manufactures specialty chemicals. The company was founded on August 23, 2000 and is headquartered in Weatherford, TX.

Shanghai Xingyao Medical Technology Development Co., Ltd. engages in the research and development, production, marketing, sale, and service of in vitro diagnostic reagents and equipment. The company was founded on May 30, 1994 and is headquartered in Shanghai, China.

Jiaxing Yakangbo Medical Laboratory Co., Ltd., established on 2011-09-02, The scope of business includes medical laboratory(clinical body fluid,blood specialty,clinical microbiology major,clinical chemistry laboratory,clinical immunization,Serology major,Clinical Cytomolecular Genetics Major);Pathology;medical instruments(one type,Class II,Three categories)research and development,wholesale,retail;Biotechnology,Technology development of medical diagnostic technology,Technical Services,technical consulting,technology transfer;Non-Certificate Vocational Skills Training for Adults;Genetic Testing Services;Genetic testing information consultation;Medical institution management consulting;Medical institution management;engaged in import and export business;Technology development of computer software,Technical Services;computer system integration,maintain.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

ABION, Inc. engages in the development of biopharmaceuticals for treating incurable diseases. Its products include protein, nucleic acid, and antibody therapeutics. The company was founded on April 16, 2007 and is headquartered in Seoul, South Korea.

SurExam Bio-Tech Co., Ltd. provides personalized medical system solutions focused on tumor molecular diagnostic products and clinical medicine testing services. Its products include medical kits. It also provides medical testing services. The company was founded on November 28, 2006 and is headquartered in Guangzhou, China.

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Beijing Lifecode Biotechnology Co., Ltd., established on 2009-07-23, The scope of business includes the sale of food;biotechnology development,technical consulting,technology transfer,Technical Services;Import and export;Agent import and export;Technology Import and Export;Enterprise Management Services;Health Advisory(Except for medical treatment activities subject to approval);Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.